SEPTEMBER, 2012 Gene-Related Patents Issued - Full patent | ||||
CHEMICAL APPARATUS | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,257,666 | Integrated active flux microfluidic devices and methods | California Institute of Technology | 4-Sep-12 | United States |
CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,268,594 | pyrC as a selection marker in Escherichia coli | Advanced Accelerator Applications S.A. | 18-Sep-12 | France |
8,257,927 | Hereditary hemochromatosis gene | Bio-Rad Laboratories, Inc. | 4-Sep-12 | United States |
8,268,568 | Methods and compositions for categorizing patients | Case Western Reserve University | 18-Sep-12 | United States |
8,268,622 | EPSPS mutants | Cibus US LLC | 18-Sep-12 | United States |
8,257,922 | Method of profiling gene expression in a subject having alzheimer's disease | GeneNews Corporation | 4-Sep-12 | United States |
8,273,534 | Predictors of patient response to treatment with EGF receptor inhibitors | Genomic Health, Inc. | 25-Sep-12 | United States |
8,273,568 | Replication-competent herpes simplex virus mediates destruction of neoplastic cells | Georgetown University | 25-Sep-12 | United States |
8,268,597 | Recombinant microorganism and method for producing L-lysine | Global Bio-Chem Technology Group Company Limited | 18-Sep-12 | Hong Kong |
8,268,609 | Production of sialylated N-glycans in lower eukaryotes | Glycofi, Inc. | 18-Sep-12 | United States |
8,257,945 | Identification of eukaryotic internal ribosome entry site (IRES) elements | Icon Genetics, Inc. | 4-Sep-12 | United States |
8,263,346 | Nonhuman model animal lacking the ability to control lymphocyte migration | Japan Science and Technology Agency | 11-Sep-12 | Japan |
8,257,920 | Method of detecting activation of notch signal transmission system | Keio University | 4-Sep-12 | Japan |
8,257,941 | Methods and platforms for drug discovery using induced pluripotent stem cells | Kyoto University | 4-Sep-12 | Japan |
8,268,583 | Cell with improved secretion mediated by MrgA protein or homologue | Novozymes A/S | 18-Sep-12 | Denmark |
8,257,915 | Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis | Progeria Research Foundation, Inc. | 4-Sep-12 | United States |
8,257,972 | Cell transformed by human Wnt3a gene | Shiseido Company, Ltd. | 4-Sep-12 | Japan |
8,268,610 | Nucleic acids useful in the manufacture of oil | Solazyme, Inc. | 18-Sep-12 | United States |
8,257,969 | Genetic suppression and replacement | The Provost Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabeth | 4-Sep-12 | Ireland |
8,257,928 | Methods for predicting and treating tumors resistant to drug, immunotherapy and radiation | The Regents of the University of California | 4-Sep-12 | United States |
8,268,619 | Method for the isolation and expansion of cardiac stem cells from biopsy | Universita Degli Studi di Roma "La Sapienza" | 18-Sep-12 | Italy |
8,257,929 | Gene expression profiling of Parkinson's Disease | University of Miami | 4-Sep-12 | United States |
8,257,919 | Micro-RNA profiles associated with endometrial cancer development and response to cisplatin and doxorubicin chemotherapy | University of South Florida | 4-Sep-12 | United States |
DATA PROCESSING | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,271,202 | Modified host bio-data management | Fernandez; Dennis S. | 18-Sep-12 | United States |
8,275,555 | Method and system for comparative genomics | International Business Machines Corporation | 25-Sep-12 | United States |
8,265,879 | Determination of single peak melting temperature by PCR analogy and double sigmoid equation | Roche Molecular Systems, Inc. | 11-Sep-12 | United States |
8,275,557 | Computer-implemented method and computer-based system for validating DNA sequencing data | SmartGene GmbH | 25-Sep-12 | Switzerland |
8,265,880 | Gene expression level analyzing method, gene expression level anlayzing program, and gene expression level analyzing device | Sony Corporation | 11-Sep-12 | Japan |
DRUG | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,268,799 | Compositions and methods for inhibiting expression of the HAMP gene | Alnylam Pharmaceuticals, Inc. | 18-Sep-12 | United States |
8,258,100 | Ligand/lytic peptide methods of use | Board of Supervisors of Louisiana State University and Agricultural and Mechanical College | 4-Sep-12 | United States |
8,263,659 | Thyroid receptor ligands | Bristol-Myers Squibb Company | 11-Sep-12 | United States |
8,273,345 | Targeted gene delivery to dendritic cells | California Institute of Technology | 25-Sep-12 | United States |
8,257,703 | Anti-ganglioside antibodies and compositions | Chugai Seiyaku Kabushiki Kaisha | 4-Sep-12 | Japan |
8,263,573 | Delivery of dsRNA to arthropods | Commonwealth Scientific and Industrial Research Organisation | 11-Sep-12 | Australia |
8,273,722 | Enhanced biotherapeutic production using inhibitory RNA | Dharmacon, Inc. | 25-Sep-12 | United States |
8,257,737 | Tissue implants and methods for making and using same | Intini; Giuseppe | 4-Sep-12 | United States |
8,263,649 | Benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof | Medifron DBT Co., Ltd. | 11-Sep-12 | Korea |
8,258,120 | 9-substituted minocycline compounds | Paratek Pharmaceuticals, Inc. | 4-Sep-12 | United States |
8,273,344 | Recombinant adeno-associated virus expressing human antisense gene CyP2J2 and its preparation methods | Tongji Hospital | 25-Sep-12 | China P. Rep. |
8,263,571 | Gene silencing of the brother of the regulator of imprinted sites (BORIS) | Vendevia Group, LLC | 11-Sep-12 | United States |
8,263,068 | Modified cells expressing a protein that modulates activity of bHLH proteins, and uses thereof | Washington State University Research Foundation | 11-Sep-12 | United States |
MULTICELLULAR LIVING ORGANISMS | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,273,955 | Spontaneous nodulation in plants | Aarhus Universitet | 25-Sep-12 | Denmark |
8,273,956 | Method for performing homologous recombination in plants | Biogemma S.A.S. | 25-Sep-12 | France |
8,273,951 | Down-regulation of gene expression using artificial micrornas | E. I. du Pont de Nemours and Company | 25-Sep-12 | United States |
8,263,822 | TREM-2 gene and protein as inhibitors of expression of GA733-2, and transgenic animals comprising the same and uses thereof | GLO Biotech | 11-Sep-12 | Korea |
8,273,953 | Antisense DNA of sweetpotato expansin cDNA and method for increasing storage root yield using the same | Korea University Industrial & Academic Collaboration Foundation | 25-Sep-12 | Korea |
8,273,954 | Genetically transformed plants | Monsanto Technology LLC | 25-Sep-12 | United States |
8,269,062 | Lunaria annua, Cardamine graeca and Teesdalia nudicaulis FAE genes and their use in producing nervonic and eicosenoic acids in seed oils | National Research Council of Canada | 18-Sep-12 | Canada |
8,269,065 | Nucleic acids and proteins associated with sucrose degradation in coffee | Nestec, S.A. | 18-Sep-12 | Switzerland |
NATURAL RESINS OR DERIVATIVES | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,268,962 | Molecules for targeting compounds to various selected organs or tissues | Prosensa Technologies B.V. | 18-Sep-12 | Netherlands |
ORGANIC COMPOUNDS | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,268,981 | Plasmodium malariae and plasmodium ovale genes and uses thereof | Abbott Laboratories | 18-Sep-12 | United States |
8,273,870 | Compositions and methods for inhibiting expression of a mutant gene | Alnylam Pharmaceuticals, Inc. | 25-Sep-12 | United States |
8,273,869 | Lipid formulated dsRNA targeting the PCSK9 gene | Alnylam Pharmaceuticals, Inc. | 25-Sep-12 | United States |
8,263,761 | Group of nucleic acid fragments for prevention of HIV infection or AIDS and the usage thereof | Beijing Solobio Genetechnology Company Ltd. | 11-Sep-12 | China P. Rep. |
8,258,287 | Interfering RNAs targeting the morbillivirus nucleoprotein gene | Centre de Cooperation Internationale en Recherche Agronomique pour le Developpment | 4-Sep-12 | France |
8,263,756 | Method of gene transfer via vascular system or ureter | Chugai Seiyaku Kabushiki Kaisha | 11-Sep-12 | Japan |
8,268,983 | Primers for amplifying and detecting the beta 2 adrenergic receptor gene | Council of Scientific & Industrial Research | 18-Sep-12 | United States |
8,268,985 | siRNA targeting amyloid beta (A4) precursor protein (APP) | Dharmacon, Inc. | 18-Sep-12 | United States |
8,268,979 | Human MutY | Human Genome Sciences, Inc. | 18-Sep-12 | United States |
8,268,986 | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) | Merck Sharp & Dohme Corp. | 18-Sep-12 | United States |
8,273,866 | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SINA) | Merck Sharp & Dohme Corp. | 25-Sep-12 | United States |
8,258,282 | Isolated nucleic acid molecules from transgenic papaya line 16-0-1 resistant to papaya ringspot virus and use thereof | National Chung Hsing University | 4-Sep-12 | Taiwan |
8,258,285 | RNA molecules and vectors for gene silencing | Plant Bioscience Limited | 4-Sep-12 | United Kingdom |
8,263,569 | Gene silencing | Plant Biosciences Limited | 11-Sep-12 | United Kingdom |
8,263,760 | Methods and means for treating DNA repeat instability associated genetic disorders | Prosensa Holding BV | 11-Sep-12 | Netherlands |
8,258,288 | RNA interference mediated inhibition of respiratory syncytial virus (RSV) expression using short interfering nucleic acid (siNA) | Sirna Therapeutics, Inc. | 4-Sep-12 | United States |
8,263,759 | Sets of probes and primers for the diagnosis of select cancers | The United States of America, as Represented by the Secretary, Department of Health and Human Services | 11-Sep-12 | United States |
Login
Advertisements
Eden's Bounty Multi-SanTM
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
TERRA+ CLEAN Acid-Replacement Surface Cleaner
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.